Advertisement
Home Tags Cancer: Misc.

Tag: Cancer: Misc.

Only half of oncologists who discuss genomic testing with patients report that they often discuss the likely costs of testing and related treatments

Many Oncologists Fail to Discuss Costs of Genomic Testing

0
About a quarter of oncologists say they rarely, never bring up costs when they discuss genomic testing

October 2019 Briefing – Hematology & Oncology

0
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for October 2019. This roundup includes...
Anticipated future shortages of oncology providers may have a serious and specific impact on women's health care

U.S. Oncologist Shortage May Impact Women’s Health

0
Major U.S. cities are expected to have a shortage of oncologists
Only one in four U.S. adults report incorporating cancer prevention into their daily lives

Survey Reveals Many Americans Lack Cancer Prevention Knowledge

0
Despite concerns about the disease, few take daily preventive actions
Women with diabetes have lower rates of breast

Cancer Screening Rates Lower Among Women With Diabetes

0
Rates for breast, cervical, colorectal cancer screening lower compared with women without diabetes
The combination of anthracyclines and radiotherapy doses to treat childhood cancer is associated with an increased risk for subsequent breast cancer

Childhood Cancer Treatment Increases Risk for Breast Cancer Later

0
Additive risk seen between combined anthracyclines and radiotherapy doses to the breast
Health insurance literacy may be an important intervention for addressing financial problems associated with cancer

Poor Health Literacy Tied to More Hardships Among Cancer Survivors

0
Individuals with low health literacy face more material, psychological, financial hardships
The risk for secondary primary malignancies varies based on stage of diffuse large B-cell lymphoma at diagnosis

Risk for Secondary Primary Cancer Varies With Lymphoma Stage

0
Risk for SPMs differs over time for survivors of diffuse large B-cell lymphoma according to stage at diagnosis
Patients with psoriasis have an increased risk for developing or dying from cancer

Risk for Cancer Incidence, Mortality Increased With Psoriasis

0
Overall cancer mortality and mortality for liver, esophageal, pancreatic cancer up with severe psoriasis
Ibrutinib is associated with an increased risk for new or worsened hypertension in patients treated for B-cell malignancies

Ibrutinib Therapy Linked to New, Worsened Hypertension

0
Ibrutinib-related hypertension associated with increased risk for major adverse cardiovascular events